The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Update concerning Guillain-Barré syndrome (GBS) following the administration of respiratory syncytial virus (RSV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback